Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert J Ossenkoppele

Showing results (31-40 of 193) with videos related to

Pageof 20
Sort By:
Leukemia & Lymphoma|October 11, 2007
Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survivalBijan Moshaver, Marjolein A van der Pol, August H Westra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Minimal residual disease in acute myeloid leukemia is predicted by an apoptosis-resistant protein profile at diagnosisAmber van Stijn, Nicole Feller, Alice Kok, et al.
The Journal of Pathology|January 21, 2010
Molecular targeted therapies for diffuse large B-cell lymphoma based on apoptosis profilesSaskia A G M Cillessen, Chris J L M Meijer, Michitaka Notoya, et al.
Cytometry. Part B, Clinical Cytometry|October 31, 2015
Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerationsCanan Alhan, Theresia M Westers, Eline M P Cremers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2006
Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targetingIlse Houtenbos, Theresia M Westers, Annemiek Dijkhuis, et al.
Leukemia Research|April 17, 2012
Azacitidine differentially affects CD4(pos) T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromesHetty J Bontkes, Jurjen M Ruben, Canan Alhan, et al.
Oncoimmunology|June 22, 2012
Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentationMarvin M van Luijn, Martine E D Chamuleau, Gert J Ossenkoppele, et al.
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cellsGerrit Jansen, Marjon Al, Yehuda G Assaraf, et al.
Blood|June 19, 2002
High numbers of active caspase 3-positive Reed-Sternberg cells in pretreatment biopsy specimens of patients with Hodgkin disease predict favorable clinical outcomeDanny F Dukers, Chris J L M Meijer, Rosita L ten Berge, et al.
Molecular Cytogenetics|November 14, 2014
Genomic amplification of MYC as double minutes in a patient with APL-like leukemiaPino J Poddighe, Hans Wessels, Pauline Merle, et al.
Pageof 20

Showing results (31-40 of 193) with videos related to

Sort By:
Pageof 20
Leukemia & Lymphoma|October 11, 2007
Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survivalBijan Moshaver, Marjolein A van der Pol, August H Westra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Minimal residual disease in acute myeloid leukemia is predicted by an apoptosis-resistant protein profile at diagnosisAmber van Stijn, Nicole Feller, Alice Kok, et al.
The Journal of Pathology|January 21, 2010
Molecular targeted therapies for diffuse large B-cell lymphoma based on apoptosis profilesSaskia A G M Cillessen, Chris J L M Meijer, Michitaka Notoya, et al.
Cytometry. Part B, Clinical Cytometry|October 31, 2015
Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerationsCanan Alhan, Theresia M Westers, Eline M P Cremers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2006
Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targetingIlse Houtenbos, Theresia M Westers, Annemiek Dijkhuis, et al.
Leukemia Research|April 17, 2012
Azacitidine differentially affects CD4(pos) T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromesHetty J Bontkes, Jurjen M Ruben, Canan Alhan, et al.
Oncoimmunology|June 22, 2012
Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentationMarvin M van Luijn, Martine E D Chamuleau, Gert J Ossenkoppele, et al.
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cellsGerrit Jansen, Marjon Al, Yehuda G Assaraf, et al.
Blood|June 19, 2002
High numbers of active caspase 3-positive Reed-Sternberg cells in pretreatment biopsy specimens of patients with Hodgkin disease predict favorable clinical outcomeDanny F Dukers, Chris J L M Meijer, Rosita L ten Berge, et al.
Molecular Cytogenetics|November 14, 2014
Genomic amplification of MYC as double minutes in a patient with APL-like leukemiaPino J Poddighe, Hans Wessels, Pauline Merle, et al.
Pageof 20